Videos de Experimentos Relacionados
El caso de la dirección olvidada.
Shanika Samarasekera1, Paul J Dorman
1Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK. shani@doctors.org.uk
Lancet (London, England)
|April 25, 2006
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Autoimmune Encephalitis in Acute Care-Pathology, Diagnosis, and Management.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author
Does adjunctive Cenobamate lead to a reduction in the use of vagal nerve stimulation? A long-term observational study of patients on the epilepsy surgery pathway.
Epilepsy & behavior : E&B·2026
Same author
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025
Same author
Refractory Status Epilepticus and Therapeutic Uncertainties: a Comprehensive Review on Targeting Neuroinflammation and Rationale for Developing a Platform Trial.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author
Guidance for: The acute management of status epilepticus in adult patients.
Journal of the Intensive Care Society·2025
Same author
Defining the typical characteristics of orthostatic headache in patients with spontaneous intracranial hypotension.
Cephalalgia : an international journal of headache·2025
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026